September 16, 2024

Supplemental Figure 3 from Myosin light chain kinase inhibition potentiates the anti-tumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor

Key points are not available for this paper at this time.

Supplemental Figure 3. GIST PDGFRA D842V PDXs are not sensitive to crenolanib.

Bookmark

Cite This Study

Rossi et al. (Mon,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark